A federal appeals panel in Manhattan reacted skeptically to arguments by a lawyer for once high-flying cryptocurrency ...
Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback